Pictet & Cie (Europe) Sa Abbott Laboratories Transaction History

Pictet & Cie (Europe) Sa

$4.19 Billion
Q3 2024

A detailed history of Pictet & Cie (Europe) Sa transactions in Abbott Laboratories stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 149,945 shares of ABT stock, worth $17.1 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

149,945

Previous 143,312 4.63%

Holding current value

$17.1 Million

Previous $14.9 Million 14.8%

% of portfolio

0.41%

Previous 0.36%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$100.07 - $118.13 $663,764 - $783,556	6,633 Added 4.63%	149,945 $17.1 Million
Q2 2024 Jul 25, 2024	BUY	$100.73 - $112.44 $1.36 Million - $1.51 Million	13,457 Added 10.36%	143,312 $14.9 Million
Q1 2024 May 07, 2024	BUY	$109.52 - $120.96 $2.25 Million - $2.48 Million	20,518 Added 18.77%	129,855 $14.8 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $983,972 - $1.2 Million	-10,910 Reduced 9.07%	109,337 $12 Million
Q3 2023 Nov 02, 2023	SELL	$95.53 - $114.62 $173,673 - $208,379	-1,818 Reduced 1.49%	120,247 $11.6 Million
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $8.18 Million - $9.11 Million	81,142 Added 198.28%	122,065 $13.3 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $207,377 - $244,095	2,141 Added 5.52%	40,923 $4.14 Million
Q4 2022 Feb 08, 2023	BUY	$95.06 - $111.52 $1.31 Million - $1.53 Million	13,747 Added 54.91%	38,782 $0
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $192,552 - $222,939	-1,990 Reduced 7.36%	25,035 $2.42 Billion
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $117,176 - $141,628	-1,148 Reduced 4.07%	27,025 $2.94 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $365,890 - $446,179	3,209 Added 12.85%	28,173 $3.34 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $46,905 - $57,432	406 Added 1.65%	24,964 $3.51 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $695,526 - $769,455	-5,962 Reduced 19.53%	24,558 $2.9 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $13 Million - $15.3 Million	-123,156 Reduced 80.14%	30,520 $3.54 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $2.54 Million - $2.99 Million	23,327 Added 17.9%	153,676 $18.4 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $10.7 Million - $11.6 Million	101,705 Added 355.07%	130,349 $14.3 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $120,873 - $146,791	1,319 Added 4.83%	28,644 $3.12 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $572,667 - $732,942	7,479 Added 37.69%	27,325 $2.5 Million
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $386,028 - $564,479	-6,145 Reduced 23.64%	19,846 $1.57 Million
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $1.39 Million - $1.55 Million	17,757 Added 215.65%	25,991 $2.26 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $1.26 Million - $1.36 Million	-15,360 Reduced 65.1%	8,234 $689,000
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $1.66 Million - $1.94 Million	-22,800 Reduced 49.14%	23,594 $1.98 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $67,544 - $81,661	-1,020 Reduced 2.15%	46,394 $3.71 Million
Q4 2018 Jan 31, 2019	SELL	$65.56 - $74.27 $437,350 - $495,455	-6,671 Reduced 12.33%	47,414 $3.43 Million
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $129,525 - $156,256	-2,130 Reduced 3.79%	54,085 $3.97 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $58,951 - $65,064	-1,024 Reduced 1.79%	56,215 $3.43 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $38,263 - $43,261	680 Added 1.2%	57,239 $3.43 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $36,234 - $38,792	675 Added 1.21%	56,559 $3.23 Million
Q3 2017 Nov 07, 2017	SELL	$48.06 - $53.64 $69,398 - $77,456	-1,444 Reduced 2.52%	55,884 $2.98 Million
Q2 2017 Aug 09, 2017	BUY	N/A	57,328	57,328 $2.79 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account

Pictet & Cie (Europe) Sa Abbott Laboratories Transaction History